We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$766M
AUM Growth
+$94.4M
Cap. Flow
+$70.2M
Cap. Flow %
9.16%
Top 10 Hldgs %
34.82%
Holding
91
New
24
Increased
10
Reduced
32
Closed
6

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$30.4M
2
BG icon
Bunge Global
BG
+$28.2M
3
CHKP icon
Check Point Software Technologies
CHKP
+$21.5M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$17.4M
5
CAG icon
Conagra Brands
CAG
+$12M

Top Sells

Rank Stock Value
1
DWA
DREAMWORKS ANIMATION SKG INC CL-A
DWA
+$17.1M
2
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
+$16.6M
3
T icon
AT&T
T
+$12.2M
4
PEP icon
PepsiCo
PEP
+$10.4M
5
ADM icon
Archer Daniels Midland
ADM
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.26%
2 Technology 16.11%
3 Financials 13.68%
4 Energy 12.49%
5 Consumer Staples 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$326B
$11.9M 1.55%
261,884
-48,176
-16% -$2.2M
TUP
27
DELISTED
Tupperware Brands Corporation
TUP
$11.1M 1.45%
128,636
-8,679
-6% -$724K
HAS icon
28
Hasbro
HAS
$13.6B
$10.8M 1.41%
229,072
-22,193
-9% -$1.04M
STT icon
29
State Street
STT
$50.2B
$10.4M 1.36%
158,338
-21,290
-12% -$1.46M
COP icon
30
ConocoPhillips
COP
$139B
$10.3M 1.35%
148,472
-22,090
-13% -$1.47M
DOV icon
31
Dover
DOV
$27.4B
$10.1M 1.31%
167,285
-20,563
-11% -$1.19M
CSX icon
32
CSX Corp
CSX
$94.2B
$9.7M 1.27%
1,130,943
-79,389
-7% -$666K
DOX icon
33
Amdocs
DOX
$5.83B
$9.49M 1.24%
258,937
-54,980
-18% -$2.08M
VIV icon
34
Telefônica Brasil
VIV
$21B
$9.14M 1.19%
+407,462
New +$8.77M
TPR icon
35
Tapestry
TPR
$30.5B
$8.79M 1.15%
161,148
+7,382
+5% +$406K
DD
36
DELISTED
Du Pont De Nemours E I
DD
$8.51M 1.11%
152,986
-123,306
-45% -$6.73M
TAP icon
37
Molson Coors Class B
TAP
$7.97B
$7.81M 1.02%
155,853
-32,970
-17% -$1.66M
HWC icon
38
Hancock Whitney
HWC
$6.19B
$7.67M 1%
244,351
-39,190
-14% -$1.27M
BRK.A icon
39
Berkshire Hathaway Class A
BRK.A
$1.1T
$7.33M 0.96%
43
– –
JCI icon
40
Johnson Controls International
JCI
$85.6B
$7.2M 0.94%
165,778
-34,820
-17% -$1.48M
NWL icon
41
Newell Brands
NWL
$2.24B
$7M 0.91%
254,644
-29,390
-10% -$783K
PTR
42
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$5.7M 0.74%
+51,818
New +$5.93M
EXC icon
43
Exelon
EXC
$48.4B
$5.53M 0.72%
261,445
-16,277
-6% -$356K
MTB icon
44
M&T Bank
MTB
$36.6B
$4.88M 0.64%
43,561
+4,370
+11% +$506K
TDW icon
45
Tidewater
TDW
$3.71B
$4.61M 0.6%
2,409
-651
-21% -$1.21M
SNY icon
46
Sanofi
SNY
$109B
$4.6M 0.6%
+90,797
New +$4.62M
EMR icon
47
Emerson Electric
EMR
$85B
$4.38M 0.57%
67,780
-9,940
-13% -$608K
SEM
48
DELISTED
Select Medical
SEM
$3.99M 0.52%
+917,235
New +$4.19M
KT icon
49
KT
KT
$8.95B
$3.91M 0.51%
+232,996
New +$3.75M
FNB icon
50
FNB Corp
FNB
$6.81B
$3.68M 0.48%
303,500
-69,570
-19% -$873K
1
2
3 4

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q3 2013 Portfolio in Review

As of Q3 2013, Foyston, Gordon, & Payne held 91 positions worth $766M, up 14% from $672M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Foyston, Gordon, & Payne deployed $70.2M of net new capital in Q3 2013, opening 24 new positions and adding to 10 existing holdings. Its largest new stake was Teva Pharmaceuticals: 780,584 shares worth $29.5M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was DREAMWORKS ANIMATION SKG INC CL-A, an estimated $17.1M trimmed.

  • Foyston, Gordon, & Payne's largest Q3 2013 buy was Teva Pharmaceuticals: 780,584 shares worth $29.5M.
  • Foyston, Gordon, & Payne added most to Conagra Brands in Q3 2013, an estimated $12M increase.
  • Foyston, Gordon, & Payne's biggest Q3 2013 reduction was DREAMWORKS ANIMATION SKG INC CL-A, cutting an estimated $17.1M.
  • Foyston, Gordon, & Payne fully exited MCGRAW-HILL FINANCIAL INC COM in Q3 2013, selling an estimated $16.6M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 35% of its $766M portfolio in Q3 2013.
  • Foyston, Gordon, & Payne opened 24 new positions and closed 6 in Q3 2013.
  • Foyston, Gordon, & Payne's portfolio value rose 14% quarter-over-quarter to $766M.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2013, filed 13 Nov 2013.